Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Cameron Wild

Showing results (111-120 of 118) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 118 results.
The International Journal on Drug Policy|February 4, 2019
Principles, practice, and policy vacuums: Policy actor views on provincial/territorial harm reduction policy in CanadaElaine Hyshka, Jalene Anderson-Baron, Arlanna Pugh, et al.
Harm Reduction Journal|July 28, 2017
Harm reduction in name, but not substance: a comparative analysis of current Canadian provincial and territorial policy frameworksElaine Hyshka, Jalene Anderson-Baron, Kamagaju Karekezi, et al.
Addiction (Abingdon, England)|June 17, 2022
Impact of fentanyl use on initiation and discontinuation of methadone and buprenorphine/naloxone among people with prescription-type opioid use disorder: secondary analysis of a Canadian treatment trialM Eugenia Socias, Evan Wood, Bernard Le Foll, et al.
The International Journal on Drug Policy|April 29, 2017
Canadian harm reduction policies: A comparative content analysis of provincial and territorial documents, 2000-2015T Cameron Wild, Bernie Pauly, Lynne Belle-Isle, et al.
Plos One|May 19, 2021
Public support for harm reduction: A population survey of Canadian adultsT Cameron Wild, Jakob Koziel, Jalene Anderson-Baron, et al.
Health Promotion and Chronic Disease Prevention in Canada : Research, Policy and Practice|September 17, 2025
The relationship between COVID-19 and opioid-related emergency department visits in Alberta, Canada: an interrupted time series analysisKelsey A Speed, Hauwa Bwala, Nicole D Gehring, et al.
The American Journal of Psychiatry|June 15, 2022
Flexible Buprenorphine/Naloxone Model of Care for Reducing Opioid Use in Individuals With Prescription-Type Opioid Use Disorder: An Open-Label, Pragmatic, Noninferiority Randomized Controlled TrialDidier Jutras-Aswad, Bernard Le Foll, Keith Ahamad, et al.
Neuroimage|July 12, 2012
Effects of emotional context on impulse controlMatthew R G Brown, R Marc Lebel, Florin Dolcos, et al.
Pageof 12

Showing results (111-120 of 118) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 118 results.
The International Journal on Drug Policy|February 4, 2019
Principles, practice, and policy vacuums: Policy actor views on provincial/territorial harm reduction policy in CanadaElaine Hyshka, Jalene Anderson-Baron, Arlanna Pugh, et al.
Harm Reduction Journal|July 28, 2017
Harm reduction in name, but not substance: a comparative analysis of current Canadian provincial and territorial policy frameworksElaine Hyshka, Jalene Anderson-Baron, Kamagaju Karekezi, et al.
Addiction (Abingdon, England)|June 17, 2022
Impact of fentanyl use on initiation and discontinuation of methadone and buprenorphine/naloxone among people with prescription-type opioid use disorder: secondary analysis of a Canadian treatment trialM Eugenia Socias, Evan Wood, Bernard Le Foll, et al.
The International Journal on Drug Policy|April 29, 2017
Canadian harm reduction policies: A comparative content analysis of provincial and territorial documents, 2000-2015T Cameron Wild, Bernie Pauly, Lynne Belle-Isle, et al.
Plos One|May 19, 2021
Public support for harm reduction: A population survey of Canadian adultsT Cameron Wild, Jakob Koziel, Jalene Anderson-Baron, et al.
Health Promotion and Chronic Disease Prevention in Canada : Research, Policy and Practice|September 17, 2025
The relationship between COVID-19 and opioid-related emergency department visits in Alberta, Canada: an interrupted time series analysisKelsey A Speed, Hauwa Bwala, Nicole D Gehring, et al.
The American Journal of Psychiatry|June 15, 2022
Flexible Buprenorphine/Naloxone Model of Care for Reducing Opioid Use in Individuals With Prescription-Type Opioid Use Disorder: An Open-Label, Pragmatic, Noninferiority Randomized Controlled TrialDidier Jutras-Aswad, Bernard Le Foll, Keith Ahamad, et al.
Neuroimage|July 12, 2012
Effects of emotional context on impulse controlMatthew R G Brown, R Marc Lebel, Florin Dolcos, et al.
Pageof 12